ACTIV-4A ACUTE: A Multicenter, Adaptive, Randomized, Open Label Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults with COVID-19

This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic and additional treatment strategies for prevention of adverse outcomes in COVID-19 positive inpatients.